Identification and Validation of IFI44 as a Novel Biomarker for Primary Sjögren’s Syndrome
Bowen Wei,1,2,* Qingyun Yue,1,2,* Yuxiu Ka,1,2,* Chenyang Sun,1,2 Yuxing Zhao,1,2 Xiaomei Ning,1,2 Yue Jin,1,2 Jingyue Gao,1,2 Yuanhao Wu,1,2 Wei Liu1,2 1Department of Rheumatism and Immunity, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tian...
Saved in:
Main Authors: | Wei B (Author), Yue Q (Author), Ka Y (Author), Sun C (Author), Zhao Y (Author), Ning X (Author), Jin Y (Author), Gao J (Author), Wu Y (Author), Liu W (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification and Clinical Correlation Analysis of IFI44 in Systemic Lupus Erythematosus Combined with Bioinformatics and Immune Infiltration Analysis
by: Wang Y, et al.
Published: (2023) -
Interferon gamma-inducible protein 16 (IFI16) and anti-IFI16 antibodies in primary Sjögren's syndrome: findings in serum and minor salivary glands
by: A. Alunno, et al.
Published: (2016) -
GANAB as a Novel Biomarker in Multiple Sclerosis: Correlation with Neuroinflammation and IFI35
by: Roberto De Masi, et al.
Published: (2021) -
CD133, but Not CD44, May Serve as a Novel Biomarker for Differential Diagnosis Between Basal Cell Carcinoma and Trichoblastomas
by: Bi Y, et al.
Published: (2022) -
FAM89A and IFI44L for distinguishing between viral and bacterial infections in children with febrile illness
by: Shufeng Tian, et al.
Published: (2021)